United States· US:0019-0862_ff628e06-2cb5-4714-a741-1dec04bd5602

Cysto-Conray II

A medicinal product containing iothalamate meglumine, registered in United States by Liebel-Flarsheim Company LLC.

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCysto-Conray IIATC—REGISTER NO.US:0019-0862_ff628e06…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
IOTHALAMATE MEGLUMINE
Manufacturer
Liebel-Flarsheim Company LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0019086250
    12 BOTTLE, GLASS in 1 BOX (0019-0862-50) / 250 mL in 1 BOTTLE, GLASS
  • ndc11
    0019-0862-50

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Iothalamate meglumine in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All iothalamate meglumine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d062ce95-0a6d-47d6-9c0d-126e4aa1e4f8
GET /v1/drugs/d062ce95-0a6d-47d6-9c0d-126e4aa1e4f8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "URETERAL",
  "source": "ndc",
  "strength": "172",
  "substance": "IOTHALAMATE MEGLUMINE",
  "productndc": "0019-0862",
  "dosage_form": "INJECTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "NDA017057",
  "marketing_category": "NDA"
}

See everything about iothalamate meglumine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.